| Trial ID: | L7027 |
| Source ID: | NCT00749047
|
| Associated Drug: |
Pioglitazone
|
| Title: |
How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Pioglitazone
|
| Outcome Measures: |
Primary: Reduction in proteinuria, 3 months | Secondary: Reduction in non-fasting plasma glucose concentration, 3 months
|
| Sponsor/Collaborators: |
Sponsor: Christchurch Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2008-09
|
| Completion Date: |
2010-03
|
| Results First Posted: |
|
| Last Update Posted: |
2009-09-16
|
| Locations: |
Christchurch Hospital, Christchurch, Canterbury, 8001, New Zealand
|
| URL: |
https://clinicaltrials.gov/show/NCT00749047
|
